Package 67184-0572-2

{"route": ["ORAL"], "spl_id": "b4283ace-4312-4cab-97c2-0722339d75b9", "openfda": {"nui": ["N0000185008", "N0000185007", "N0000182137", "N0000190114", "N0000185503"], "upc": ["0367184057214", "0367184057221", "0367184057122", "0367184057115"], "unii": ["MVR3JL3B2V"], "rxcui": ["1300791", "1300801"], "spl_set_id": ["98247602-29b9-4621-8eeb-519e40b883b9"], "pharm_class_epc": ["beta3-Adrenergic Agonist [EPC]"], "pharm_class_moa": ["Adrenergic beta3-Agonists [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Qilu Pharmaceutical Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0572-1)", "package_ndc": "67184-0572-1", "marketing_start_date": "20250630"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0572-2)", "package_ndc": "67184-0572-2", "marketing_start_date": "20250630"}], "brand_name": "Mirabgeorn", "product_id": "67184-0572_b4283ace-4312-4cab-97c2-0722339d75b9", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Adrenergic beta3-Agonists [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "beta3-Adrenergic Agonist [EPC]"], "product_ndc": "67184-0572", "generic_name": "mirabegron", "labeler_name": "Qilu Pharmaceutical Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Mirabgeorn", "active_ingredients": [{"name": "MIRABEGRON", "strength": "50 mg/1"}], "application_number": "ANDA217989", "marketing_category": "ANDA", "marketing_start_date": "20250630", "listing_expiration_date": "20261231"}